Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer’s Disease Hallmarks.

dc.contributor.author
Griñán Ferré, Christian
dc.contributor.author
Jarne Ferrer, Júlia
dc.contributor.author
Bellver Sanchis, Aina
dc.contributor.author
Ribalta Vilella, Marta
dc.contributor.author
Barroso Fernández, Emma
dc.contributor.author
Salvador, Jesús M.
dc.contributor.author
Jurado Aguilar, Javier
dc.contributor.author
Palomer Tarridas, Francesc Xavier
dc.contributor.author
Vázquez Carrera, Manuel
dc.contributor.author
Pallàs i Llibería, Mercè, 1964-
dc.date.issued
2024-04-16T07:38:42Z
dc.date.issued
2024-04-16T07:38:42Z
dc.date.issued
2024-02-23
dc.date.issued
2024-04-16T07:38:47Z
dc.identifier
1661-6596
dc.identifier
https://hdl.handle.net/2445/210000
dc.identifier
747771
dc.description.abstract
<p><em>Gadd45 genes have been implicated in survival mechanisms, including apoptosis, autophagy,</em></p><p><em>cell cycle arrest, and DNA repair, which are processes related to aging and life span. Here, we</em></p><p><em>analyzed if the deletion of Gadd45a activates pathways involved in neurodegenerative disorders such</em></p><p><em>as Alzheimer’s Disease (AD). This study used wild-type (WT) and Gadd45a knockout (Gadd45a−/−)</em></p><p><em>mice to evaluate AD progression. Behavioral tests showed that Gadd45a−/− mice presented lower</em></p><p><em>working and spatial memory, pointing out an apparent cognitive impairment compared with WT</em></p><p><em>animals, accompanied by an increase in Tau hyperphosphorylation and the levels of kinases involved</em></p><p><em>in its phosphorylation in the hippocampus. Moreover, Gadd45a−/− animals significantly increased the</em></p><p><em>brain’s pro-inflammatory cytokines and modified autophagy markers. Notably, neurotrophins and</em></p><p><em>the dendritic spine length of the neurons were reduced in Gadd45a−/− mice, which could contribute</em></p><p><em>to the cognitive alterations observed in these animals. Overall, these findings demonstrate that the</em></p><p><em>lack of the Gadd45a gene activates several pathways that exacerbate AD pathology, suggesting that</em></p><p><em>promoting this protein’s expression or function might be a promising therapeutic strategy to slow</em></p><p><em>down AD progression.</em></p>
dc.format
1 p.
dc.format
application/pdf
dc.format
application/pdf
dc.language
eng
dc.publisher
MDPI
dc.relation
Reproducció del document publicat a:
dc.relation
International Journal of Molecular Sciences, 2024
dc.rights
cc-by (c) Griñán-Ferré C et al., 2024
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject
Malaltia d'Alzheimer
dc.subject
Malalties neurodegeneratives
dc.subject
Epigenètica
dc.subject
Alzheimer's disease
dc.subject
Neurodegenerative Diseases
dc.subject
Epigenetics
dc.title
Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer’s Disease Hallmarks.
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)